Amplia Therapeutics Limited

Amplia Therapeutics Limitedverified

INNMF

Price:

$0.082

Market Cap:

$57.49M

Established in 2000 and headquartered in Melbourne, Australia, Amplia Therapeutics Limited is a pharmaceutical firm dedicated to the discovery and development of focal adhesion kinase (FAK) inhibitors. The company's therapeutic endeavors are concentrated on oncology (cancer) and chronic fibrotic diseases. Its drug development pipeline includes AMP945, a FAK inhibitor that has successfully completed Phase I clinical trials and is being explored for its efficacy in treating pancreatic cancer, idiopathic pulmonary fibrosis, and a broader spectrum of cancerous and fibrotic conditions. Another compound, AMP886, is also under development for potential applications in cancer and fibrotic disorders....[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

INNMF

The Enterprise Value as of June 2026 (TTM) for Amplia Therapeutics Limited (INNMF) is 29.98M

According to Amplia Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 29.98M. This represents a change of -32.90% compared to the average of 44.68M of the last 4 quarters.

Amplia Therapeutics Limited (INNMF) Historical Enterprise Value (quarterly & annually)

How has INNMF Enterprise Value performed in the past?

The mean historical Enterprise Value of Amplia Therapeutics Limited over the last ten years is 32.38M. The current 29.98M Enterprise Value has changed 9.16% with respect to the historical average. Over the past ten years (40 quarters), INNMF's Enterprise Value was at its highest in in the March 2017 quarter at 145.70M. The Enterprise Value was at its lowest in in the March 2011 quarter at -483539.00.

Quarterly (TTM)
Annual

Average

32.38M

Median

11.68M

Minimum

1.62M

Maximum

157.11M

Amplia Therapeutics Limited (INNMF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amplia Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.26%

Maximum Annual Enterprise Value = 157.11M

Minimum Annual Increase = -90.50%

Minimum Annual Enterprise Value = 1.62M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202682.85M678.12%
202510.65M-16.29%
202412.72M33.89%
20239.50M18.70%
20228.00M-63.75%
202122.08M1.26%
20201.62M-62.54%
20194.34M-70.96%
201814.93M-90.50%
2017157.11M416.54%

Amplia Therapeutics Limited (INNMF) Average Enterprise Value

How has INNMF Enterprise Value performed in the past?

The current Enterprise Value of Amplia Therapeutics Limited (INNMF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

35.41M

5-year avg

24.75M

10-year avg

32.38M

Amplia Therapeutics Limited (INNMF) Enterprise Value vs. Peers

How is INNMF’s Enterprise Value compared to its peers?

Amplia Therapeutics Limited’s Enterprise Value is less than MindMaze Therapeutics Holding S.A. (0), less than Oncotelic Therapeutics, Inc. (16.73T), less than MindMaze Therapeutics Holding S.A. Sponsored ADR (0), greater than PsyBio Therapeutics Corp. (135.91K), less than Helix BioPharma Corp. (118.19M), greater than ZIVO Bioscience, Inc. (14.84M), less than Arch Biopartners Inc. (36.94M), less than Calliditas Therapeutics Ab (11.24B), less than Cynata Therapeutics Limited (60.71M), less than Covalon Technologies Ltd. (45.14M),

Build a custom stock screener for Amplia Therapeutics Limited (INNMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amplia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amplia Therapeutics Limited (INNMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amplia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amplia Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Amplia Therapeutics Limited (INNMF)?

What is the 3-year average Enterprise Value for Amplia Therapeutics Limited (INNMF)?

What is the 5-year average Enterprise Value for Amplia Therapeutics Limited (INNMF)?

How does the current Enterprise Value for Amplia Therapeutics Limited (INNMF) compare to its historical average?